We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$321M
AUM Growth
+$58M
Cap. Flow
+$56.4M
Cap. Flow %
17.58%
Top 10 Hldgs %
57.18%
Holding
275
New
60
Increased
44
Reduced
12
Closed
150
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
101
Quest Diagnostics
DGX
$26.3B
$3K ﹤0.01%
+18
New +$2.63K
HOLX
102
DELISTED
Hologic
HOLX
$3K ﹤0.01%
+38
New +$2.85K
RVTY icon
103
Revvity
RVTY
$12.8B
$3K ﹤0.01%
+17
New +$3K
WAT icon
104
Waters Corp
WAT
$39.9B
$3K ﹤0.01%
+9
New +$3.52K
QGEN icon
105
Qiagen
QGEN
$8.72B
$2K ﹤0.01%
+34
New +$1.89K
BPMC
106
DELISTED
Blueprint Medicines
BPMC
$1K ﹤0.01%
+8
New +$745
BRKR icon
107
Bruker
BRKR
$8.14B
$1K ﹤0.01%
+16
New +$1.33K
CPRX
108
DELISTED
Catalyst Pharmaceutical
CPRX
$1K ﹤0.01%
+125
New +$684
CRSP icon
109
CRISPR Therapeutics
CRSP
$5.17B
$1K ﹤0.01%
+11
New +$1.38K
EHC icon
110
Encompass Health
EHC
$12.4B
$1K ﹤0.01%
+19
New +$1.2K
FLGT icon
111
Fulgent Genetics
FLGT
$527M
$1K ﹤0.01%
+7
New +$636
GMED icon
112
Globus Medical
GMED
$11.2B
$1K ﹤0.01%
+15
New +$1.2K
HALO icon
113
Halozyme
HALO
$12.2B
$1K ﹤0.01%
+21
New +$878
INMD icon
114
InMode
INMD
$880M
$1K ﹤0.01%
+10
New +$610
INVA icon
115
Innoviva
INVA
$1.48B
$1K ﹤0.01%
+41
New +$613
IRWD icon
116
Ironwood Pharmaceuticals
IRWD
$714M
$1K ﹤0.01%
+51
New +$659
LMAT icon
117
LeMaitre Vascular
LMAT
$1.86B
$1K ﹤0.01%
+11
New +$620
ORGO icon
118
Organogenesis Holdings
ORGO
$239M
$1K ﹤0.01%
+41
New +$637
PCRX icon
119
Pacira BioSciences
PCRX
$997M
$1K ﹤0.01%
+11
New +$634
PINC
120
DELISTED
Premier
PINC
$1K ﹤0.01%
+17
New +$627
QDEL icon
121
QuidelOrtho
QDEL
$838M
$1K ﹤0.01%
+5
New +$672
QURE icon
122
uniQure
QURE
$3.22B
$1K ﹤0.01%
+18
New +$549
SAGE
123
DELISTED
Sage Therapeutics
SAGE
$1K ﹤0.01%
+14
New +$642
VIVO
124
DELISTED
Meridian Bioscience Inc
VIVO
$1K ﹤0.01%
+32
New +$638
ATRS
125
DELISTED
Antares Pharma, Inc.
ATRS
$1K ﹤0.01%
+170
New +$687

Similar funds

Anfield Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Anfield Capital Management held 275 positions worth $321M, up 22% from $263M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Anfield Capital Management deployed $56.4M of net new capital in Q3 2021, opening 60 new positions and adding to 44 existing holdings. Its largest new stake was Invesco QQQ Trust: 31,422 shares worth $11.2M.

By sector, the portfolio is most concentrated in Financials at 2.9% of assets, up from 2.9% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was BlackRock Floating Rate Income Strategies Fund, an estimated $221K trimmed.

  • Anfield Capital Management's largest Q3 2021 buy was Invesco QQQ Trust: 31,422 shares worth $11.2M.
  • Anfield Capital Management added most to iShares US Treasury Bond ETF in Q3 2021, an estimated $3.16M increase.
  • Anfield Capital Management's biggest Q3 2021 reduction was BlackRock Floating Rate Income Strategies Fund, cutting an estimated $221K.
  • Anfield Capital Management fully exited Anfield Dynamic Fixed Income ETF in Q3 2021, selling an estimated $2.83M.
  • Anfield Capital Management's ten largest holdings make up 57% of its $321M portfolio in Q3 2021.
  • Anfield Capital Management opened 60 new positions and closed 150 in Q3 2021.
  • Anfield Capital Management's portfolio value rose 22% quarter-over-quarter to $321M.

Based on Anfield Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.